124 related articles for article (PubMed ID: 15222702)
1. The MS Co-Operative REsearch (MS-CORE) group: an alternate approach to fostering multicenter studies.
Cohen J; Cutter G; Lublin F; Schwid S
Mult Scler; 2004 Jun; 10(3):332-3. PubMed ID: 15222702
[No Abstract] [Full Text] [Related]
2. Towards a european network for multiple sclerosis trials (ENMST).
Kappos L; Polman C; Thompson AJ; Duda P; Clanet M; Comi G; Hartung HP; Montalban X
Mult Scler; 2003 Dec; 9(6):627-9. PubMed ID: 14664478
[TBL] [Abstract][Full Text] [Related]
3. In the news: Treatment guidelines and positive trials at ECTRIMS.
Fyfe I
Nat Rev Neurol; 2016 Nov; 12(11):614. PubMed ID: 27713489
[No Abstract] [Full Text] [Related]
4. [The unique judgement in multicenter clinical trials: the new Spanish normative in the European frame].
Dal-Ré R
Med Clin (Barc); 2005 Feb; 124(7):263-5. PubMed ID: 15743593
[No Abstract] [Full Text] [Related]
5. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies.
De Stefano N; Filippi M; Miller D; Pouwels PJ; Rovira A; Gass A; Enzinger C; Matthews PM; Arnold DL
Neurology; 2007 Nov; 69(20):1942-52. PubMed ID: 17998486
[TBL] [Abstract][Full Text] [Related]
6. Getting it right: industry sponsorship and medical research.
Baird P
CMAJ; 2003 May; 168(10):1267-9. PubMed ID: 12743071
[No Abstract] [Full Text] [Related]
7. Conducting a European multi-center trial: first experiences with the new EU Clinical Trials Directive from an academic perspective.
Delawi D; Dhert WJ; Oner FC
Eur Spine J; 2008 Aug; 17(8):1113-5. PubMed ID: 18551324
[No Abstract] [Full Text] [Related]
8. [New regulation for multicenter clinical trials and its repercussions on the function of current clinical trial ethics committees].
García Herrera JL
Rev Esp Quimioter; 2003 Dec; 16(4):383-4. PubMed ID: 14961130
[No Abstract] [Full Text] [Related]
9. Site qualification in multicenter clinical trials.
McEwan AS; Graham MM; Conti PS
J Nucl Med; 2009 Aug; 50(8):30N. PubMed ID: 19652215
[No Abstract] [Full Text] [Related]
10. [A multicenter clinical JCOG-LSG trial, from a protocol coordinator's standpoint].
Ohmachi K
Rinsho Ketsueki; 2006 Jul; 47(7):571-8. PubMed ID: 16910565
[No Abstract] [Full Text] [Related]
11. Should there be an accredited ethics committee system for centralised review of multicentre clinical research?
Cohen M
Med J Aust; 1998 May; 168(10):528. PubMed ID: 9631688
[No Abstract] [Full Text] [Related]
12. Should there be an accredited ethics committee system for centralised review of multicentre clinical research?
Gandevia SC; McKeown T; Wright MM; Briody GP; Watson JD
Med J Aust; 1998 Sep; 169(5):285. PubMed ID: 9762073
[No Abstract] [Full Text] [Related]
13. Should there be an accredited ethics committee system for centralised review of multicentre clinical research?
O'Brien EA; Saltman DC; Berglund CA
Med J Aust; 1998 Sep; 169(5):284-5. PubMed ID: 9762072
[No Abstract] [Full Text] [Related]
14. Should there be an accredited ethics committee system for centralised review of multicentre clinical research?
Henman MJ; Tattersall MH; Brown RF
Med J Aust; 1998 Sep; 169(5):283-4. PubMed ID: 9762071
[No Abstract] [Full Text] [Related]
15. Should there be an accredited ethics committee system for centralised review of multicentre clinical research?
Clarke CW
Med J Aust; 1998 Sep; 169(5):283. PubMed ID: 9762070
[No Abstract] [Full Text] [Related]
16. [Regulation of the evaluation process of multicentric clinical trials in Spain].
Arnau JM; Fuentes I; Laporte JR
Med Clin (Barc); 2003 Jul; 121(5):197; author reply 197. PubMed ID: 12867010
[No Abstract] [Full Text] [Related]
17. Children's oncology group looks to increase efficiency, numbers in clinical trials.
Benowitz S
J Natl Cancer Inst; 2000 Dec; 92(23):1876-8. PubMed ID: 11106677
[No Abstract] [Full Text] [Related]
18. [Data and reflection on the current process of evaluation of multicenter clinical trials in Spain].
Gil Aguado A; Lavilla Uriol P; Fernández de Uzquiano E
Rev Clin Esp; 2007 Dec; 207(11):586-7; author reply 587. PubMed ID: 18021654
[No Abstract] [Full Text] [Related]
19. Symposium on quality assurance and good clinical practice (GCP) in cancer drug development.
Kranich AL; Gastl G; Maier-Lenz H; Nagel GA
J Cancer Res Clin Oncol; 1994; 120(10):625-7. PubMed ID: 7929536
[No Abstract] [Full Text] [Related]
20. Altered peptide ligands and MS treatment.
Conlon P; Steinman L
Science; 2002 Jun; 296(5574):1801-2; author reply 1801-2. PubMed ID: 12053936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
